MRC PAYMENT AGREEMENT (MEDI-7734) between MEDIMMUNE LIMITED And VIELA BIO, INC. Dated as of February 23, 2018MRC Payment Agreement • August 29th, 2019 • Viela Bio, Inc. • Pharmaceutical preparations • England and Wales
This MRC Payment Agreement (this “Agreement”) is made by way of a deed and entered into as of February 23, 2018 (the “Effective Date”) by and between MedImmune Limited, a company formed and registered under the laws of England and Wales, whose registered office is at Milstein Building, Granta Park, Cambridge, CB21 6GH (and which is a member of the AstraZeneca group of companies) (“MedImmune”) and Viela Bio, Inc., a Delaware corporation (“Spinco”). MedImmune and Spinco are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
